A simple standardization of esophageal photodynamic therapy light dosimetry is proposed.
Introduction
Photodynamic therapy (PDT) is becoming more widely used in clinical practice: from the treatment of early and late stage cancers to retinal macular degeneration (1, 2) . It has been established that by following rigorous protocols for photosensitizing drug administration and light activation, significant improvements in patient outcomes can be achieved.
The mechanism for PDT involves the photoactivation of a sensitizing drug that is differentially up taken by abnormal tissue. Treatment localization is achieved by combing differential uptake with targeted illumination. Cell death can be caused by a number of mechanisms, depending on the target site of the photosensitizing agents within tissues.
The scope of this paper covers discussion of the standardization of esophageal PDT treatment protocols; although these concepts are applicable to other applications. It is hoped that this will improve the reproducibility of patient outcomes and enhance the possibility of direct comparison between treatments using different light sources and delivery devices.
Early clinical work in photodynamic therapy has involved research teams comprised of clinicians, scientists, pharmacists and nursing staff. The treatment regime is usually controlled by a clinician who selects the drug dose (usually calculated by body mass) and a physicist or dosimetrist who calculates the light dose to be delivered to the region of interest. It is important that repeatable treatment regimes are followed to allow rigorous statistical comparison between studies to be made; thus allowing establishment of optimum protocols. Furthermore simplification or standardization of protocols will allow practitioners to fully understand the effects of the protocols followed and allow accurate dosimetry to be achieved routinely by clinical staff alone. Within the area of esophageal PDT there are a number of areas of discrepancy:
1. The use of a diffuser fiber alone versus a diffuser coupled to a centering device. 2. The method of calculating light dose to be given.
As research groups have developed their treatment regimes they have followed their own procedures for calculation of 'light dose' and 'fluence rates'. Joules per cm (Jcm -1 ) of diffuser fiber length versus Joules per square cm of treatment area (Jcm -2 ). a. This has lead to unwelcome variation in treatment doses per unit area for differing treatment lengths.
b. This has caused confusion with some workers and Jcm -2 are sometimes mistakenly replaced with Jcm -1 and vice versa, even in guideline documents (3) .
The effects of all these issues on the reproducibility of treatment regimes between centers and between patients with differing treatment lengths will be discussed below.
Diffuser/balloon Combinations Versus Diffusers Alone
The emission profile, of fiber diffusers used for PDT, is a very important and commonly ignored parameter. Approximations are often made in the calculation of light dosimetry. These include uniform emission from the diffuser fiber in both circumferential and axial directions. A number of studies have been performed to study this characteristic (4). Early diffusing fibers had a tendency to show strongly forward directed radiation patterns (5). Figure 1 shows the emission profile of a 3 cm bare diffusing fiber (manufactured in house). It can be seen that more light is emitted towards the distil tip than the proximal end of the fiber diffuser. The angular radiance distribution of several newer diffusers have been evaluated elsewhere (6). These proved to be more effective in providing a uniform light distribution at a fixed distance from the surface.
Even cylindrical diffusers with a perfectly uniform emission profile when placed freely in the esophagus fail to provide a homogeneous field of irradiation due to inaccuracies in concentric positioning within the lumen. Islands of cylindrical epithelium may partly persist when Barrett's esophagus with severe dysplasia or early carcinoma is being treated, and incomplete destruction of the dysplastic and malignant mucosa has been observed (7). The simple calculations outlined below demonstrate the effect on local treatment dose of using diffusing fibers within the esophageal lumen without any centering device.
The calculations have been made using the following assumptions:
1. The esophageal lumen is cylindrical (usually the case only if dilated), with a diameter of 2.5 cm.
2. The light is uniformly emitted perpendicular to the diffuser surface.
Stone
Technology 3. No movement of the diffuser fiber is possible along the distil-proximal axis.
A total energy output of 200
Jcm -1 of diffusing fiber length has been used.
5. All light incident upon the esophageal wall is not reflected back into the lumen. a Figure 2 shows the effect on the treatment dose of the diffusing fiber moving off axis. A set of isodose plots indicate the irradiated dose to the region encompassed with that particular curve. The left hand example shows perfect alignment and the isodose plot below it demonstrates that approximately 25 Jcm -2 would be delivered to the mucosal surface of the esophagus (with 200 Jcm -1 input to the fiber). However if the diffuser were slightly off axis, i.e. half way between the center of the lumen and the wall, then the treatment dose ranges from approximately 17 to 35 Jcm -2 . Finally if the diffuser were close to the mucosal surface (actually quite likely), then the treatment doses would range from approximately 150 to 13 Jcm -2 . As we can see this is an unsatisfactory state of affairs. It may be that an overdose does little harm in many PDT applications due to the photo bleaching of the sensitizing drug, however significant under-dosing of the mucosa will be likely to leave islands of viable abnormal tissue, with potentially significant consequences for the patient.
The effect of poor positioning of the fiber within the esophageal lumen demonstrates the need for a centering device, such as a Perspex dilator ( Figure 3a ) or balloon device (Figure 3b ). Furthermore as discussed above the light distribution from the edges of the diffusing fibers can be less than uniform. It can be seen that surrounding the fiber diffuser with a medium of larger refractive index than air can improve the light distribution. See Figure 4 ; a plot of the output profile measured from a diffuser within a Perspex dilator. Application of devices to compensate for the variability of the output profile can be helpful, for example the reflective ended balloon provides an optimized centering device with a uniform light emission profile. The traditional design includes the facility to insert a diffusing fiber into the center of the balloon, with a length of diffuser (often 1 cm) sitting at either end of the balloon within the reflective end regions. The development of these balloons has had a great effect on minimizing the non-uniformity of diffuser output at the ends of the fiber. Overholt et al. demonstrated improved light delivery systems appeared to reduce the incidence of stricture (8).
It is important to note that centering balloons used within hollow lumen should fill the treatment volume, but not apply pressure to the tissue surface. The effect of compressing the surface can reduce blood flow to the treatment area and hence reduce the supply of oxygen, a necessary component of the induced phototoxicity. Panjepour et al.
(9, 10) intimated that the balloon pressure could affect the treatment outcomes. Too high a pressure and oxygen levels in the tissue surface can reduce and limit the effects of the PDT, too low a pressure and the balloon may not be fully inflated and hence a non-uniform field would be incident upon the tissue. 2 cm diameter balloons have been experimented with to minimize the compression effect. However a This is not usually the case and therefore actual absorbed light dose can be higher, however calculations of the illumination dose are usually accepted practice to provide repeatable regimes. it has been found that 2.5 cm balloons are often required to fully fill the lumen of the esophagus and reduce the movement of the balloon during treatment.
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Significantly more complex light distribution systems have been established for the various applications of PDT, including areas such as the uterus (11).
Potential Dose Calculation Discrepancy
A number of groups have used non-standard units such as dose per unit length of diffuser (Jcm -1 ) and fluence rate per unit length of diffuser (mWcm -1 ) to enable ease of use in certain applications. However for direct comparison between studies utilizing different photosensitizers and illumination geometries the use of light dose per unit area (or Jcm -2 ) gives an absolute measure of the light illuminating the surface of the treatment volume. Furthermore there are some published articles where it appears that the authors have been confused by these differences in units and mixed them up, thereby inadvertently suggesting that a patient should be significantly over-or under-dosed.
In addition the use of the units of dose per unit length of diffusing fiber has brought further confusion when the fibre is placed in a windowed balloon to improve uniformity of illumination within lumen such as the esophagus. It is often the case with these balloons that reflecting ends are used within the balloon to provide uniform illumination and diffusing fiber tips are up to 2 cm longer than the balloon window. Therefore if one uses the units of Jcm -1 of diffuser length within a balloon, this has the effect of changing the dose per unit area of tissue treated, depending on the length of fibre used. See Table I (for this example the fiber has been placed within a centering windowed balloon of diameter 25 mm). It must be noted that there is the contribution from the 1 cm at either end of the balloon, which is disproportionately large in smaller balloons.
In the example above 200 Jcm -1 of diffuser length would produce a treatment dose of 76.4 Jcm -2 in a 3 cm fiber/1 cm balloon window configuration and 42.4 Jcm -2 in a 5 cm fiber/3 cm window configuration. Figure 5 is a plot of illumination dose to the surface versus fiber diffuser length for a constant energy per unit diffuser length output (an often used treatment protocol). It can be seen that there is a significant variation in light dose for different treatment lengths.
A recent clinical trial for photofrin (follow up at 2 year stage) (12) utilized diffusing fibers and reflective-end balloons for uniform treatment fields and short diffusers for topping up missed areas or overdosing visible lesions. The dosimetry for this trial was calculated from the length of the fiber dif- fuser within the balloon at 130 Jcm -1 . It can be observed by looking at Figure 5 that the dose per unit area treatment region varies significantly with the length of the diffuser fiber. Balloon/fiber combinations were used in the range of 5 to 9 cm for this trial. This plot illustrates the need for a standardized calculation of treatment dose per unit area to provide repeatable treatment regimes and to enable more direct comparison between treatment outcomes.
Incident Irradiance Versus Actual Light Fluence
Star (13) has proposed the need to calculate dosimetry on measured total fluence rather than incident irradiance. This is because not all light incident upon the treatment area is absorbed. A fraction is scattered back to add to the fluence of light on the surface elsewhere. Therefore the actual fluence rate is often significantly higher than the incident irradiance. This will not matter in the cases where the optical properties of treated tissues are the same from one treatment to the next, i.e. the treatment doses that are deemed to be effective and not harmful can be defined by incident irradiance unless in some conditions patients present with regions of tissue more highly scattering or absorbing than others. In a study to evaluate the effect of different fluence rates on the treatment of bronchial mucosa in pig with mTHCP and Photofrin it was observed that inter-animal variations in fluence rate were measured for comparible illumination conditions (14).
A more complex approach for light dosimetry has been proposed by others. This involves the use of online monitoring of light fluence during PDT (15, 16) use intraperitonealy or endo-bronchially, where treatments are at non-uniform diameters and surfaces. This is thought to be unnecessary and excessively costly for general use in uniform organs.
Conclusions
There are many potential photosensitizers and illumination options for PDT. The best method for identification of the optimum treatment for a particular condition is to publish data on well designed trials that include information on the light dosimetry regime. This must be kept constant throughout the trial unless the study is to evaluate the effects of different dosimetry regimes. The use of the same units and uniform light fields by all groups can only improve the reproducibility of these treatments and in the long-term improve the outcomes for all patients. Furthermore the effect of variable fluence rates and fractionated doses are undergoing study by many groups.
Finally, it is proposed that all esophageal PDT treatments are performed with the following:
1. Use of centering device and high quality fiber diffusers.
2. Irradiated treatment dose calculated using Jcm -2 and fluence rate calculated using mWcm -2 of effective treatment area.
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